Lifesign RSV rapid diagnostic test, available in a box of 25, for point-of-care detection of respiratory syncytial virus antigen in clinical specimens. Provides rapid results to support timely clinical decision-making for patients presenting with respiratory illness in skilled nursing facilities, long-term care communities, and outpatient settings. Early RSV identification supports appropriate isolation measures, treatment initiation, and outbreak management, particularly important in elderly and immunocompromised patient populations. CLIA-waived for use in qualified point-of-care testing environments. A valuable diagnostic tool for infection control and preventive care programs in facilities managing respiratory illness risks during RSV season.